• 1
    Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
  • 2
    Welch KM & Levine SR. Migraine-related stroke in the context of the International Headache Society classification of head pain. Arch Neurol. 1990;47:458-462.
  • 3
    Luda E, Bo E, Sicuro L, Comitangelo R, Campana M. Sustained visual aura: a totally new variation of migraine. Headache. 1991;31:582-583.
  • 4
    Liu GT, Schatz NJ, Galetta SL, Volpe NJ, Skobieranda F, Kosmorsky GS. Persistent positive visual phenomena in migraine. Neurology. 1995;45:664-668.
  • 5
    Buchholz DW & Reich SG. The menagerie of migraine. Semin Neurol. 1996;16:83-93.
  • 6
    Rothrock JF. Successful treatment of persistent migraine aura with divalproex sodium. Neurology. 1997;48:261-262.
  • 7
    D'Andrea G, Granella F, Cadaldini M, Manzoni GC. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia. 1999;19:64-66.
  • 8
    Lees G & Leach MJ. Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Res. 1993;612:190-199.
  • 9
    Welch KM, Barkley GL, Tepley N, Ramadan NM. Central neurogenic mechanisms of migraine. Neurology. 1993;43(suppl 3):S21-S25.
  • 10
    Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994;117(pt 1):199-210.
  • 11
    Mathew NT, Mullani NA, Gould KL. Migraine with persistent visual aura: sustained metabolic activation in the medial occipital cortex measured by PET [abstract]. Neurology. 1998;50(suppl 4):A350-A351.